Kukizaki, Japan

Humio Tamura


Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 117(Granted Patents)


Location History:

  • Hino, JA (1977)
  • Koganei, JP (1981)
  • Ibaraki, JP (1982)
  • Kukizaki, JP (1980 - 1990)
  • Inashiki, JP (1990)

Company Filing History:


Years Active: 1977-1990

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Humio Tamura: Innovator in Fluorescent Substances and Anti-Tumor Agents

Introduction

Humio Tamura is a notable inventor based in Kukizaki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of fluorescent substances and anti-tumor agents. With a total of 11 patents to his name, Tamura's work has had a considerable impact on medical and scientific research.

Latest Patents

Among his latest patents, Tamura has developed chlorambucil derivatives and a cell-discriminating agent that includes a fluorescent substance. This invention encompasses a process for producing the fluorescent substance, which is represented by a specific formula. Additionally, he has created an injection containing 3-benzoyloxy-1,3,5(10)-estratriene-17-[4-{p-bis(2-chloroethyl)amino)phenyl }butanoyloxy]acetate, known for its use as an orally administrable anti-tumor substance.

Career Highlights

Tamura is associated with Kureha Kagaku Kogyo Kabushiki Kaisha, where he continues to innovate and contribute to the field. His work has been instrumental in advancing the understanding and application of fluorescent materials in medical science.

Collaborations

Throughout his career, Tamura has collaborated with esteemed colleagues such as Kiro Asano and Hiromitsu Tanaka. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

Humio Tamura's contributions to the field of chemistry, particularly in the development of fluorescent substances and anti-tumor agents, highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the medical and research communities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…